Abstract
The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.
Author supplied keywords
Cite
CITATION STYLE
François, B., Chastre, J., Eggiman, P., Laterre, P. F., Torres, A., Sanchez, M., … Jafri, H. S. (2016). The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia. Clinical Infectious Diseases, 63, S46–S51. https://doi.org/10.1093/cid/ciw245
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
